Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer

ClinicalTrials.gov ID: NCT00003862

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00003862. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 12:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Trial of Preoperative Chemotherapy and Chemoradiotherapy for Potentially Resectable Adenocarcinoma of the Stomach

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of chemotherapy and radiation therapy in treating patients who have stomach cancer.

Study identification

NCT ID
NCT00003862
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

Drug · Procedure · Radiation

Eligibility (public fields only)

Age range
0 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 1999 (Type not available)
Primary completion
Nov 2004 (Actual)
Completion
Not listed
Last update posted
Oct 19, 2020

Started 1999

United States locations

U.S. sites
55
U.S. states
23
U.S. cities
49
Facility City State ZIP Site status
Providence Alaska Medical Center Anchorage Alaska 99519-6604 —
Foundation for Cancer Research and Education Phoenix Arizona 85013 —
Mount Diablo Medical Center Concord California 94524-4110 —
Northridge Hospital Medical Center Northridge California 91328 —
University of California Davis Cancer Center Sacramento California 95817 —
Penrose - St. Francis Health Services Colorado Springs Colorado 80933 —
St. Joseph Hospital Denver Colorado 80218-1191 —
Presbyterian-St Luke's Medical Center Denver Colorado 80218 —
Rose Medical Center Denver Colorado 80220 —
CCOP - Colorado Cancer Research Program, Incorporated Denver Colorado 80224 —
Swedish Medical Center Englewood Colorado 80110 —
St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center Grand Junction Colorado 81502-1628 —
CCOP - Atlanta Regional Atlanta Georgia 30342-1701 —
Lutheran General Hospital Cancer Care Center Park Ridge Illinois 60068 —
Indiana University Cancer Center Indianapolis Indiana 46202-5289 —
Veterans Affairs Medical Center - Indianapolis (Roudebush) Indianapolis Indiana 46202 —
Ball Memorial Hospital Cancer Center Muncie Indiana 47303-3499 —
Porter Memorial Hospital Valparaiso Indiana 46383 —
Wendt Regional Cancer Center of Finley Hospital Dubuque Iowa 52001 —
McLaren Regional Cancer Center Flint Michigan 48532-3685 —
Ellis Fischel Cancer Center at University of Missouri - Columbia Columbia Missouri 65203 —
CCOP - Kansas City Kansas City Missouri 64131 —
Methodist Hospital Cancer Center at Nebraska Methodist Hospital - Omaha Omaha Nebraska 68114-4199 —
Norris Cotton Cancer Center at Dartmouth Medical School Lebanon New Hampshire 03756-0002 —
Monmouth Medical Center Long Branch New Jersey 07740-6395 —
Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Mount Holly New Jersey 08060 —
Fox Chase Cancer Center at St. Francis Medical Center Trenton New Jersey 08629 —
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C. Syracuse New York 13217 —
Presbyterian Hospital Charlotte North Carolina 28233-3549 —
Wayne Memorial Hospital, Inc. Goldsboro North Carolina 27533 —
Leo W. Jenkins Cancer Center of University Health Systems of Eastern Carolina Greenville North Carolina 27835-6028 —
Ireland Cancer Center Cleveland Ohio 44106-5065 —
CCOP - Dayton Dayton Ohio 45429 —
CCOP - Toledo Community Hospital Toledo Ohio 43623-3456 —
St. Luke's Hospital Cancer Center Bethlehem Pennsylvania 18015 —
Bryn Mawr Hospital Bryn Mawr Pennsylvania 19010 —
Mercy Fitzgerald Hospital Darby Pennsylvania 19023 —
Delaware County Memorial Hospital Drexel Hill Pennsylvania 19026 —
Paoli Memorial Hospital Paoli Pennsylvania 19301-1792 —
Albert Einstein Cancer Center Philadelphia Pennsylvania 19141-3098 —
Western Pennsylvania Hospital Pittsburgh Pennsylvania 15224 —
CCOP - MainLine Health Wynnewood Pennsylvania 19096 —
Lankenau Cancer Center at Lankenau Hospital Wynnewood Pennsylvania 19096 —
Greenville Hospital System Greenville South Carolina 29605 —
CCOP - Greenville Greenville South Carolina 29615 —
CCOP - Upstate Carolina Spartanburg South Carolina 29303 —
Rapid City Regional Hospital Rapid City South Dakota 57709 —
Harrington Cancer Center Amarillo Texas 79106 —
University of Texas - MD Anderson Cancer Center Houston Texas 77030-4009 —
McKay-Dee Hospital Center Ogden Utah 84403 —
Utah Valley Regional Medical Center - Provo Provo Utah 84604 —
LDS Hospital Salt Lake City Utah 84143 —
University of Washington Medical Center Seattle Washington 98195-6043 —
CCOP - Marshfield Clinic Research Foundation Marshfield Wisconsin 54449 —
Columbia Hospital Milwaukee Wisconsin 53211 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003862, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 19, 2020 · Synced Nov 15, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.